Belando, Roselyn .

HRN: 27-37-09  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/24/2025
CEFUROXIME 500MG (TAB)
06/24/2025
07/01/2025
ORAL
500mg
BID
S/P NSD With Repair
Checking Initial Appropriateness 
06/25/2025
CEFUROXIME 1.5GM (VIAL)
06/25/2025
06/26/2025
IV
1.5 G
Q8
Urinary Tract Infection
Checking Initial Appropriateness 
06/25/2025
CEFUROXIME 1.5GM (VIAL)
06/25/2025
06/26/2025
IV
1.5 G
Q8
Urinary Tract Infection
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: